Targeting CXCR2 signaling in inflammatory lung diseases: neutrophil-driven inflammation and emerging therapies. - Hussain MS; Goyal A; Goyal K; S RJ; Nellore J; Shahwan M; Rekha A; Ali H; Dhanasekaran M; MacLoughlin R; Dua K; Gupta G (Naunyn-Schmiedeberg's archives of pharmacology, 2025)